Covance
Executive Summary
Closing of two satellite offices in Walnut Creek, Calif., and Dublin, Ireland, is part of Covance's plan to restructure Phase III clinical trial operations. About 200 positions will be eliminated globally, leaving about 1,500 employees dedicated to Phase III operations. The majority of the restructuring will be complete by the end of the second quarter, when Covance will report a charge of about $15 mil